KaliVir Immunotherapeutics issues three new drug patents
The U.S. Patent and Trademark Office recently issued Pittsburgh-based KaliVir Immunotherapeutics, a clinical-stage biotechnology company developing multimechanistic oncolytic viral immunotherapy progr...
Read More